Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/15/24 → 08/4/26 |
Funding
- REDNVIA Company Limited: $93,133.35
Amarex: An Adaptive Phase 2/3 Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel, 3 Arm Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease with Mild to Moderate....
- Kort, Smadar (PI)
- Parikh, Puja B (CoPI)
Project: Research